amino acid precursors to glutathione Newly revealed function could be used boost antioxidant levels The Amino Company

Description

In vivo studies showed that a high-fat diet exacerbated OA, but n-3 PUFAs reduced disease severity by lowering inflammation and cartilage breakdown, and n-6 PUFAs had no deleterious effects on the condition (149)

Administration Timing and Duration Published studies show variation in treatment duration based on the tissue and injury model: Acute injury models: Treatment typically begins immediately (within 24 hours) and continues for 2-4 weeks Chronic condition models: Treatment periods extend to 4-8 weeks, with some investigations running 12 weeks to assess long-term remodelling Preventative models: Some studies administer BPC-157 before injury induction, showing protective effects even when dosing occurs 24 hours prior to damage The peptides half-life has not been extensively characterised in published pharmacokinetic studies, but dosing intervals of 12-24 hours appear standard across most protocols, suggesting sufficient duration of action to avoid multiple daily administrations in many research contexts